Epilepsili Yetişkinlerde Epilepsi Bilgi Düzeyi ile Tamamlayıcı ve Alternatif Tıp Kullanımı Arasındaki İlişki

Abstract

ÖZ Amaç Bu çalışmanın amacı, epilepsili bireylerde tamamlayıcı ve alternatif tıp (TAT) kullanım özelliklerini belirlemek ve hastalık farkındalığı ile ilişkisini değerlendirmektir. Gereç ve Yöntemler Çalışma, Ekim 2024 ile Ocak 2025 tarihleri arasında Türkiye'nin doğusundaki bir ilde 325 epilepsi hastası ile yürütüldü. Veri toplamak için TAT kullanım özellikleri hakkında 16 soru içeren kişisel bilgi formu ve epilepsi bilgi ölçeği kullanıldı. Verilerin analizinde ki-kare, t-testi, ANOVA ve Pearson korelasyon analizi kullanıldı. Analizler, IBM SPSS Statistics 27 yazılımı ile %95 güven aralığında ve p<0,05 anlamlılık düzeyinde gerçekleştirildi. Bulgular Ortalama epilepsi süresi 5,58 ± 3,44 yıldır. Katılımcıların %45,5'inin levetirasetam kullandığı, %21,8'inin epilepsi için bir TAT yöntemi kullandığı, %63,4'ünün genel sağlıklarını iyileştirmek için TAT kullandığı, %87,3'ünün bitkisel yöntemleri tercih ettiği ve %50,7'sinin orta düzeyde olumlu etkiler bildirdiği bulundu. TAT kullanımı, düşük gelirli bireylerde, yaygın epilepsi hastalarında ve ilaç kullanmayanlarda (p=0,003; p<0,001; p=0,000) anlamlı derecede daha yaygındı. Sonuç Katılımcıların beşte biri TAT yöntemlerini kullanmış ve en çok tercih edilen yöntem bitkisel ilaçlar olmuştur. Yaygın epilepsi hastaları ve antinöbet ilaç kullanmayanlar, TAT kullanmaya daha yatkındı. Sağlık uzmanları tarafından alınan tıbbi öykülerde TAT kullanımı hakkında bilgi verilmesi, potansiyel TAT kullanıcılarının belirlenmesine ve böylece epilepsi tedavi sürecine katkıda bulunmaya yardımcı olabilir.

Keywords

• Epilepsi farkındalığı
• epilepsy bilgisi
• tamamlayıcı tıp.

The Relationship Between Epilepsy Knowledge Level and Complementary and Alternative Medicine Use in Adults with Epilepsy

Abstract

ABSTRACT Objective The aim of this study was to determine the characteristics of complementary and alternative medicine (CAM) use in individuals with epilepsy and assess its relationship with disease awareness. Material and Methods The study was conducted between October 2024 and January 2025 with 325 people with epilepsy (PWE) in a province in Eastern Turkey. A personal information form containing 16 questions about CAM usage characteristics and an epilepsy knowledge scale were used to collect data. Chi-square, t-test, ANOVA, and Pearson correlation analysis were used to analyze the data. Analyses were performed with IBM SPSS Statistics 27 software at a 95% confidence interval and a significance level of p<0.05. Results The average duration of epilepsy was 5.58 ± 3.44 years. It was found that 45.5% of PWE used levetiracetam, 21.8% used a CAM method for epilepsy, 63.4% used CAM to improve general health, 87.3% preferred herbal methods, and 50.7% reported moderate positive effects. CAM usage was significantly more common among individuals with low income, generalized epilepsy, and those not using medication (p=0.003; p<0.001; p=0.000). Conclusion One-fifth of the participants used CAM methods, with herbal medicines being the most preferred method. Those with generalized epilepsy and those not using antiseizure drugs (ASDs) were more inclined to use CAM. Including information on CAM use in medical histories taken by healthcare professionals can help identify potential CAM users, thus contributing to the treatment process of epilepsy.

Keywords

• Epilepsy awareness
• epilepsy knowledge
• complementary medicine.

References

1. 1.WHO. Epilepsy Fact Sheet; 2024. Available from: http://www.who. int/mediacentre/factsheets/fs999/en/. Accessed December 27, 2024. [Internet]. Available from: Available from: http://www.who. int/mediacentre/factsheets/fs999/en/. Accessed December 27, 2024.
2. 2.Allahverdiyev O, Dzhafar S, Berköz M, Yıldırım M. Advances in current medication and new therapeutic approaches in epilepsy. East J Med [Internet]. 2018 [cited 2024 Dec 22];23.
3. 3.Farrukh MJ, Makmor Bakry M, Hatah E, Jan TH. Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: a systematic review. Patient Prefer Adherence. 2018;Volume 12:2111–2121. doi: 10.2147/PPA.S179031.
4. 4.Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban- Gil KR, Bergqvist AGC, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DAJE, Liu YM, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Sfaström CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3:175–192. doi: 10.1002/epi4.12225.
5. 5.Liu H, Yang Y, Wang Y, Tang H, Zhang F, Zhang Y, Zhao Y. Ketogenic diet for treatment of intractable epilepsy in adults: A meta‐analysis of observational studies. Epilepsia Open. 2018;3:9–17. doi: 10.1002/epi4.12098.
6. 6.Jeong MJ, Lee HY, Lim JH, Yun YJ. Current utilization and influencing factors of complementary and alternative medicine among children with neuropsychiatric disease: a cross-sectional survey in Korea. BMC Complement Altern Med. 2016;16:91. doi: 10.1186/s12906-016-1066-4.
7. 7.Tan M, Kavurmaci M. Complementary And Alternative Medicine Use In Turkish Patients With Epilepsy. Altern Ther Health Med [Internet]. 2021 [cited 2024 Dec 22];27.
8. 8.Jasamai M, Islahudin F, Samsuddin NF. Attitudes towards complementary alternative medicine among Malaysian adults. J Appl Pharm Sci. 2017;7:190–193.

9. 9.Asadi-Pooya AA, Brigo F, Lattanzi S, Karakis I, Asadollahi M, Trinka E, El Ghoneimy LT, Pretorius C, Contreras G, Daza-Restrepo A. Complementary and alternative medicine in epilepsy: A global survey of physicians’ opinions. Epilepsy Behav. 2021;117:107835.
10. 10.Tolchin B, Goldstein LH, Reuber M, Stone J, Perez DL, LaFrance WC Jr, Fobian AD, Dorman J, Hua LH, Errico ZP, Swanson S, Gilli P, Mildon B, Takahashi J, Botchway-Doe K, Hameed KP, Silsbee H, Oskoui M. Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology. 2026;106:e214466. doi: 10.1212/WNL.0000000000214466.
11. 11.Ghinea N. An Analysis of Australia’s Legal Framework for Access to More Affordable but Unapproved Medicines and Biologics. J Bioethical Inq. 2025;22:639–649.
12. 12.Coker MF, Bhargava S, Fitzgerald M, Doherty CP. What do people with epilepsy know about their condition? Evaluation of a subspecialty clinic population. Seizure. 2011;20:55–59.
13. 13.Degirmenci Y, Karaman HIO, Bakar C. Perceptions of epilepsy of three different groups in Turkey. Epilepsy Behav. 2010;19:315–322.
14. 14.Eren F, Öztürk Ş. Epilepside hastalığın gizlenme durumu ve uyku kalitesinin değerlendirilmesi. Türk Epilepsi Ile Savaş Derneği. 2019;25:76–80.
15. 15.Aydemir N. Developing two different measures for assessing knowledge of and attitudes toward epilepsy for the Turkish population. Epilepsy Behav. 2008;12:84–89.
16. 16.Sirven JI, Drazkowski JF, Zimmerman RS, Bortz JJ, Shulman DL, Macleish M. Complementary/ alternative medicine for epilepsy in Arizona. Neurology. 2003;61:576–577. doi: 10.1212/01.WNL.0000073541.08356.47.
17. 17.Chapman SC, Horne R, Chater A, Hukins D, Smithson WH. Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav. 2014;31:312–320.
18. 18.Kim IJ, Kang JK, Lee SA. Factors contributing to the use of complementary and alternative medicine by people with epilepsy. Epilepsy Behav. 2006;8:620–624.
19. 19.Tandon M, Prabhakar S, Pandhi P. Pattern of use of complementary/alternative medicine (CAM) in epileptic patients in a tertiary care hospital in India. Pharmacoepidemiol Drug Saf. 2002;11:457–463. doi: 10.1002/pds.731.
20. 20.Easterford K, Clough P, Comish S, Lawton L, Duncan S. The use of complementary medicines and alternative practitioners in a cohort of patients with epilepsy. Epilepsy Behav. 2005;6:59–62.
21. 21.Liow K, Ablah E, Nguyen JC, Sadler T, Wolfe D, Tran KD, Guo L, Hoang T. Pattern and frequency of use of complementary and alternative medicine among patients with epilepsy in the midwestern United States. Epilepsy Behav. 2007;10:576–582.
22. 22.Kuan YC, Yen DJ, Yiu CH, Lin YY, Kwan SY, Chen C, Chou CC, Yu HY. Treatment-seeking behavior of people with epilepsy in Taiwan: a preliminary study. Epilepsy Behav. 2011;22:308–312.
23. 23.Bodeker G, Kronenberg F. A Public Health Agenda for Traditional, Complementary, and Alternative Medicine. Am J Public Health. 2002;92:1582–1591. doi: 10.2105/AJPH.92.10.1582.
24. 24.Bosak M, Słowik A. Use of complementary and alternative medicine among adults with epilepsy in a university epilepsy clinic in Poland. Epilepsy Behav. 2019;98:40–44.
25. 25.Kumar M, Ramanujam B, Barki S, Dwivedi R, Vibha D, Singh RK, Tripathi M. Impact of exercise as a complementary management strategy in people with epilepsy: A randomized controlled trial. Epilepsy Behav. 2022;129:108616.
26. 26.Can V, Bulduk M, Ayşin N, Can EK, Aydın N. Determination of complementary and alternative medicine use frequency and related factors in children with epilepsy: A descriptive Cross-Sectional study from eastern Turkey. Epilepsy Behav. 2024;160:110041.
27. 27.İnce T, İnce G, Üzüm Ö, Aydın A. Parent-reported complementary and alternative medicine use among pediatric patients with epilepsy at two tertiary centers in Turkey–Prevalence and pre Koh MY, Khor SB, Lim KS, Fong SL, Low WZ, Yeap LL, Tan CT. Use of complementary and alternative medicine among adult with epilepsy-experiences from a single epilepsy center in Malaysia. Neurosci Res Notes. 2022;5:109–109.
28. 28.Koh MY, Khor SB, Lim KS, Fong SL, Low WZ, Yeap LL, Tan CT. Use of complementary and alternative medicine among adult with epilepsy-experiences from a single epilepsy center in Malaysia. Neurosci Res Notes. 2022;5:109–109.
29. 29.Mesraoua B, Kissani N, Deleu D, Elsheikh L, Ali M, Melikyan G, Al Hail H, Wiebe S, Asadi-Pooya AA. Complementary and alternative medicine (CAM) for epilepsy treatment in the Middle East and North Africa (MENA) region. Epilepsy Res. 2021;170:106538.
30. 30.Liu W, Ge T, Pan Z, Leng Y, Lv J, Li B. The effects of herbal medicine on epilepsy. Oncotarget. 2017;8:48385.
31. 31.Case R, Blake S. A Practical Guide to Supporting People with Epilepsy [Internet]. Cham: Springer International Publishing; 2020 [cited 2025 Sept 10]. Available from: http://link.springer.com/10.1007/978-3-030-42675-0.
32. 32.Farrukh MJ, Makmor BM, Hatah E, Jan TH. Impact of complementary and alternative medicines on antiepileptic medication adherence among epilepsy patients. BMC Complement Med Ther. 2021;21:50. doi: 10.1186/s12906-021-03224-2.
33. 33.Naja F, Alameddine M, Itani L, Shoaib H, Hariri D, Talhouk S. The Use of Complementary and Alternative Medicine among Lebanese Adults: Results from a National Survey. Evid Based Complement Alternat Med. 2015;2015:1–9. doi: 10.1155/2015/682397.
34. 34.Peterson CL, Piccenna L, Williams S, Batchelor F, Dow B, Shears G. Older people and knowledge of epilepsy: GPs can help. Aust Fam Physician. 2017;46:132–136. Cited in PMID: 28260276.
35. 35.Pauschek J, Bernhard MK, Syrbe S, Nickel P, Neininger MP, Merkenschlager A, Kiess W, Bertsche T, Bertsche A. Epilepsy in children and adolescents: disease concepts, practical knowledge, and coping. Epilepsy Behav. 2016;59:77–82.
36. 36.Mameniskiene R, Sakalauskaite JE, Budrys V. People with epilepsy lack knowledge about their disease. Epilepsy Behav. 2015;46:192–197.